High YES1 protein expression was an independent predictor for poor prognosis in patients with NSCLC, and they indicated that SFKs may serve as potential therapeutic targets by the examination of YES1 genetic alteration in NSCLC. Here, YES1 is linked to non-small cell lung carcinoma.